发明名称 |
Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
摘要 |
It has been discovered that beta-L-2'-deoxynucleosides are active against drug-resistant hepatitis B virus with mutations. A method for treating lamivudine resistant HBV (M552V) in a host is provided that includes administering a beta-L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug. In addition, a method for preventing lamivudine resistant HBV (M552V) mutation from occurring in a naïve host is provided that includes administering a beta-L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug. A method for preventing and/or suppressing the emergence of the HBV double mutant (L528M/M552V) in a host is also provided that includes administering a beta-L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug.
|
申请公布号 |
US2005080034(A1) |
申请公布日期 |
2005.04.14 |
申请号 |
US20030662641 |
申请日期 |
2003.09.15 |
申请人 |
STANDRING DAVID;SOMMADOSSI JEAN-PIERRE;PATTY APRIL L.;SEIFER MARIA |
发明人 |
STANDRING DAVID;SOMMADOSSI JEAN-PIERRE;PATTY APRIL L.;SEIFER MARIA |
分类号 |
A61K31/7068;A61K31/7072;A61K31/7076;A61K38/21;A61K45/06;A61P31/12;(IPC1-7):A61K31/707;A61K31/707;A61K31/52 |
主分类号 |
A61K31/7068 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|